FDA Inspection 920920 — Anshi Pharmaceutical (Zhongshan) Inc.
The FDA completed an inspection of Anshi Pharmaceutical (Zhongshan) Inc. on March 20, 2015 in Zhongshan. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 20, 2015
- Fiscal Year
- 2015
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Zhongshan (China)